Arrr! Bispecific antibodies be sinkin' like a ship in a storm, matey! Not so good in the real seas!
2024-12-07
Arrr, me hearties! In the briny deep o' reality, usin' epcoritamab and glofitamab fer that pesky large B-cell lymphoma be like sailin' into a storm—ye end up in Davy Jones' locker instead o' the treasure! Aye, trials be trickin' ye, savvy?
Ahoy, me hearties! Gather 'round and lend yer ears to a tale of woe from the high seas of medicine! It seems that the scallywags tryin' to treat that pesky beast known as relapsed/refractory large B-cell lymphoma with the potions o' epcoritamab and glofitamab be findin' themselves in a right pickle!Now, in the safe harbors of clinical trials, them fancy treatments be sailin' smooth, with outcomes lookin' as bright as a treasure chest full o' gold. But, lo and behold, once they set sail into the turbulent waters of the real world, the story takes a turn for the worse! Aye, the outcomes be poorer than a landlubber tryin' to navigate a stormy sea without a compass!
Ye see, the learned folks at Medscape Medical News be shoutin' from the crow’s nest that what works in the controlled confines of trials don't always do the trick when faced with the fierce winds and waves of reality. So, if ye be thinkin' of employin' these treatments, best be prepared for a bumpy ride, me mateys! Keep yer cutlasses sharp and yer spirits high, for the battle against this villainous lymphoma be a treacherous one!